Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 146.00
+0.50 (0.34%)
At close: Mar 26, 2026
Diaceutics Market Cap
Diaceutics has a market cap or net worth of 123.98 million as of March 26, 2026. Its market cap has increased by 12.82% in one year.
Market Cap
123.98M
Enterprise Value
114.73M
Revenue
34.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
146.00
Market Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 123.98M, an increase of 86.57%. That is a compound annual growth rate of 9.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 123.55M | 13.68% |
| Dec 31, 2025 | 108.69M | 2.47% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 218.10B |
| GSK plc | 82.14B |
| Haleon | 32.31B |
| Smith & Nephew | 10.28B |
| Tristel | 178.54M |
| Animalcare Group | 167.78M |
| Optima Health | 159.80M |
| Scancell Holdings | 121.94M |